| Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus (NCT02472795) | Viatris Innovation GmbH | 2015-06-01 |
| Pregnancy and Medically Assisted Conception in Rare Diseases (NCT02450396) | Assistance Publique - Hôpitaux de Paris | 2015-06-01 |
| A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus (NCT02465580) | Peking University People's Hospital | 2015-06-01 |
| Web-based Genetic Research on Lupus (NCT02530944) | 23andMe, Inc. | 2015-05-01 |
| Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases (NCT04786431) | Universidade Nova de Lisboa | 2015-03-01 |
| Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment (NCT07102030) | Region Stockholm | 2015-02-15 |
| Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients (NCT02307643) | Tanabe Pharma Corporation | 2015-02-01 |
| Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus (NCT02364908) | University Hospital, Lille | 2014-12-01 |
| Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood (NCT02306629) | UCB Biopharma S.P.R.L. | 2014-11-01 |
| Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients (NCT02321709) | Sanofi | 2014-11-01 |
| Activity and Nutrition Trial in Lupus to Energize and Renew (NCT02281513) | Northwestern University | 2014-10-01 |
| Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy (NCT02270970) | Oklahoma Medical Research Foundation | 2014-10-01 |
| Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB) (NCT02102594) | Charite University, Berlin, Germany | 2014-10-01 |
| Prediction of Outcome of Lupus Nephritis (NCT02403115) | Istituto Giannina Gaslini | 2014-10-01 |
| A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. (NCT02185040) | Celgene | 2014-09-16 |
| Nelfinavir in Systemic Lupus Erythematosus (NCT02066311) | Northwell Health | 2014-09-01 |
| Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment (NCT02330250) | Oswaldo Cruz Foundation | 2014-07-01 |
| Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus (NCT02194400) | Resolve Therapeutics | 2014-07-01 |
| A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector (NCT02124798) | GlaxoSmithKline | 2014-05-20 |
| Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients (NCT02119156) | GlaxoSmithKline | 2014-05-13 |
| Omega 3 in LES and APS (NCT01956188) | University of Sao Paulo | 2014-05-01 |
| Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 (Litifilimab) in Healthy Volunteers and Participants With Systemic Lupus Erythematosus (NCT02106897) | Biogen | 2014-04-30 |
| Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus (NCT02456168) | Northwell Health | 2014-01-21 |
| Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases (NCT01988506) | Assistance Publique - Hôpitaux de Paris | 2014-01-06 |
| Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus (NCT02319525) | University of Alabama at Birmingham | 2014-01-01 |
| Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness (NCT02453880) | Stanford University | 2014-01-01 |
| Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches (NCT02270957) | Oklahoma Medical Research Foundation | 2014-01-01 |
| Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus (NCT02558517) | Groupe Hospitalier Pitie-Salpetriere | 2014-01-01 |
| A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects (NCT01894360) | GlaxoSmithKline | 2013-10-14 |
| A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184 (NCT01953835) | GlaxoSmithKline | 2013-10-04 |
| Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region (NCT03138941) | Monash University | 2013-09-01 |
| Low-dose IL-2( Interleukin-2) Treatment in SLE (NCT02084238) | Peking University People's Hospital | 2013-08-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus (NCT01709474) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-06-01 |
| Intervention to Improve Quality of Life in African American Lupus Patients (NCT01837875) | Medical University of South Carolina | 2013-04-01 |
| Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease (NCT02270710) | Weill Medical College of Cornell University | 2013-04-01 |
| The Effect of Calcitriol on Progress and Activity of Lupus Nephritis (NCT01863641) | Guilan University of Medical Sciences | 2013-04-01 |
| An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184 (NCT01777256) | GlaxoSmithKline | 2013-03-01 |
| Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry (NCT01729455) | GlaxoSmithKline | 2013-02-21 |
| Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) (NCT01632241) | Human Genome Sciences Inc., a GSK Company | 2013-02-19 |
| Aerobic Exercise on Improving Sleep in Systemic Lupus Erythematosus. (NCT02037971) | Federal University of São Paulo | 2013-02-01 |
| CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus (NCT01395745) | Anthera Pharmaceuticals | 2013-02-01 |
| Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) (NCT01781611) | Oklahoma Medical Research Foundation | 2013-02-01 |
| Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients (NCT01741012) | Wayne State University | 2013-01-01 |
| International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus (NCT01509989) | Assistance Publique - Hôpitaux de Paris | 2013-01-01 |
| Belimumab Assessment of Safety in SLE (NCT01705977) | GlaxoSmithKline | 2012-11-27 |
| Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy. (NCT01687192) | University Hospital, Bordeaux | 2012-10-11 |
| A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment (NCT01689350) | Sun Yat-sen University | 2012-10-01 |
| Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy (NCT01649765) | GlaxoSmithKline | 2012-09-07 |
| An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE) (NCT01689025) | Novo Nordisk A/S | 2012-09-01 |
| Belimumab (BENLYSTA®) Pregnancy Registry (NCT01532310) | GlaxoSmithKline | 2012-07-16 |
| Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments (NCT01642706) | University Hospital, Montpellier | 2012-07-02 |
| Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus. (NCT01892748) | ROSA MARIA RODRIGUES PEREIRA | 2012-07-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender (NCT01687309) | GlaxoSmithKline | 2012-04-30 |
| Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus. (NCT01559090) | AstraZeneca | 2012-04-20 |
| Atacicept Demonstrating Dose RESponSe (NCT01440231) | EMD Serono | 2012-02-01 |
| GADD34 and Type I IFN Response Genes in SLE (NCT03206359) | University Hospital, Grenoble | 2012-01-25 |
| A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus (NCT01438489) | MedImmune LLC | 2012-01-01 |
| Catalytic Antibodies and Lupus in Martinique (NCT01157468) | University Hospital Center of Martinique | 2012-01-01 |
| On Open-Label Study in Participants With Systemic Lupus Erythematosus (NCT01488708) | Eli Lilly and Company | 2012-01-01 |
| Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus (NCT01741857) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2012-01-01 |
| Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects (NCT01534403) | UCB Pharma | 2012-01-01 |
| Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus (NCT02021513) | University of Texas Southwestern Medical Center | 2012-01-01 |
| Japanese phase1 Study of Belimumab (IV vs SC) (NCT01516450) | GlaxoSmithKline | 2011-12-26 |
| CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE) (NCT01520155) | Johann Wolfgang Goethe University Hospital | 2011-12-01 |
| A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) (NCT01484496) | Human Genome Sciences Inc., a GSK Company | 2011-11-16 |
| Zostavax in Systemic Lupus Erythematosus (NCT01474720) | Oklahoma Medical Research Foundation | 2011-11-01 |
| Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE) (NCT01460680) | Tel-Aviv Sourasky Medical Center | 2011-11-01 |
| The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients (NCT01359826) | Loma Linda University | 2011-10-01 |
| Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) (NCT01449071) | UCB Pharma | 2011-10-01 |
| Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus (NCT01408576) | UCB Pharma | 2011-07-01 |
| Vitamin D to Improve Endothelial Function in SLE (NCT01911169) | Medical University of South Carolina | 2011-06-01 |
| A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (NCT01305746) | Anthera Pharmaceuticals | 2011-04-01 |
| A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus (NCT01283139) | MedImmune LLC | 2011-03-31 |
| Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus (NCT03979976) | Federal University of São Paulo | 2011-03-01 |
| Levothyroxine in Pregnant SLE Patients (NCT01276782) | Johns Hopkins University | 2011-01-01 |
| A Study of LY2127399 in Participants With Systemic Lupus Erythematosus (NCT01205438) | Eli Lilly and Company | 2011-01-01 |
| A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus (NCT01240694) | Cephalon, Inc. | 2010-12-09 |
| Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus Erythematosus (NCT01269866) | Dr. Jesus Gutierrez Stone | 2010-12-01 |
| Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (NCT01262365) | UCB Pharma | 2010-12-01 |
| Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia (NCT01549184) | Henri Mondor University Hospital | 2010-12-01 |
| Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) (NCT01261793) | UCB Pharma | 2010-12-01 |
| A Study of LY2127399 in Participants With Systemic Lupus Erythematosus (NCT01196091) | Eli Lilly and Company | 2010-12-01 |
| Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children (NCT01330368) | Children's Hospital of Philadelphia | 2010-10-01 |
| Physical Exercise, Endothelial Function and Progenitor Endothelial Cells in Systemic Lupus Erythematosus Patients (NCT01712529) | Federal University of São Paulo | 2010-09-01 |
| Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) (NCT01475149) | Hospital for Special Surgery, New York | 2010-09-01 |
| Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus (NCT01164917) | Amgen | 2010-08-01 |
| Balancing Lupus Experiences With Stress Strategies (NCT01351662) | Medical University of South Carolina | 2010-08-01 |
| A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis (NCT00979654) | MedImmune LLC | 2010-08-01 |
| Effectiveness Study of Psychotherapy in Systemic Lupus Erythematosus (NCT01840709) | Federal University of São Paulo | 2010-08-01 |
| Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE) (NCT01176643) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2010-08-01 |
| Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE) (NCT01381536) | GlaxoSmithKline | 2010-07-20 |
| PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus (NCT01162681) | Anthera Pharmaceuticals | 2010-07-01 |
| A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE) (NCT01135459) | Cephalon, Inc. | 2010-06-24 |
| The Research Registry for Neonatal Lupus (NCT00074373) | NYU Langone Health | 2010-05-27 |
| Exercise and Systemic Lupus Erythematosus (NCT01515163) | University of Sao Paulo | 2010-05-01 |
| The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE) (NCT01425775) | University of Alexandria | 2010-04-01 |
| The Role of ITGAM in Systemic Lupus Erythematosus (NCT01230112) | Northwell Health | 2009-12-01 |
| Reducing Depressive Symptoms in Systemic Lupus Erythematosus (NCT01120652) | University of Pittsburgh | 2009-11-01 |
| Cardiology Prevention in Systemic Lupus Erythematosus (SLE) (NCT00610805) | University of Pittsburgh | 2009-11-01 |